 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 38 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Singleton A. on PAPER: Lobsiger CS. et al., 2007, Recommendation Only. 2 Nov 2007.
|
|
|
 |
|
|
Singleton A. on PAPER: Luzón-Toro B. et al., 2007, Recommendation Only. 2 Jul 2007.
|
|
|
|
|
|
Singleton A. on PAPER: Amador-Ortiz C. et al., 2007, Recommendation Only. 6 May 2007.
|
|
|
|
|
|
Singleton A. on PAPER: Lünemann JD. et al., 2007, Recommendation Only. 6 May 2007.
|
|
|
|
|
|
Singleton A. on PAPER: Ito G. et al., 2007, Recommendation Only. 30 Mar 2007.
|
|
|
|
|
|
Singleton A. on PAPER: Kallhoff V. et al., 2007, Recommendation Only. 26 Mar 2007.
|
|
|
|
|
|
Singleton A. on PAPER: Mukherjee O. et al., 2007, Recommendation Only. 13 Feb 2007.
|
|
|
|
|
|
Singleton A. on PAPER: Li D. et al., 2006, This is an interesting papee. Although it seems out of left field, the authors present evidence... 1 Jan 2007.
|
|
|
|
|
|
Singleton A. on PAPER: Lam YC. et al., 2006, Recommendation Only. 1 Jan 2007.
|
|
|
|
|
|
Singleton A. on PAPER: Klünemann HH. et al., 2006 Oct-Dec, Recommendation Only. 2 Dec 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Neumann M. et al., 2006, Recommendation Only. 17 Oct 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Juling K. et al., 2006, Although these data are preliminary, I think they are interesting. They suggest that non-coding... 12 Oct 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Willem M. et al., 2006, Recommendation Only. 3 Oct 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Bové J. et al., 2006, One of an interesting set of articles that deals with the proteasome inhibition model of... 27 Sep 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Bové J. et al., 2006, Recommendation Only. 27 Sep 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Kordower JH. et al., 2006, Recommendation Only. 27 Sep 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Gass J. et al., 2006, Recommendation Only. 18 Sep 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Hoe HS. et al., 2006, Recommendation Only. 18 Sep 2006.
|
|
|
|
|
|
Singleton A. on PAPER: de la Torre JC. et al., 2006, Recommendation Only. 18 Sep 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Cabrejo L. et al., 2006, Recommendation Only. 18 Sep 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Schwarz DS. et al., 2006, Recommendation Only. 18 Sep 2006.
|
|
|
|
|
|
Singleton A. on PAPER: van der Flier WM. et al., 2006, This paper presents interesting but preliminary data showing an increased E4 frequency in... 17 Aug 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Braakman N. et al., 2006, Recommendation Only. 17 Aug 2006.
|
|
|
|
|
|
Singleton A. on NEWS: Highs and Lows: Overactive Synuclein Promoter Linked to Parkinson’s, Tau Loss to Mental Retardation, This study builds upon existing genotyping and combines studies to provide a compelling... 17 Aug 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Collinge J. et al., 2006, The authors show long incubation periods (~50 years) in patients with Kuru. This may be of... 26 Jul 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Giedraitis V. et al., 2006, An interesting paper assessing a dozen Swedish families with AD in an attempt to identify a new... 26 Jul 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Dekkers W. et al., 2006, This interesting manuscript uses AD as the working example to examine the concept of "genetic... 26 Jul 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Jeynes B. et al., 2006, Recommendation Only. 26 Jul 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Orimo S. et al., 2006, Recommendation Only. 26 Jul 2006.
|
|
|
|
|
|
Singleton A. on PAPER: Farrer MJ. et al., 2006, Recommendation Only. 12 Jul 2006.
|
|
|
|
|
|
|
1 to 30 of 38 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our latest Webinar: 
